Research Ethics Board

Safety Confidentiality Quality Protect Research Participants

Starting Fall 2022, the NYGH Research Ethics Board (REB) is electronic!

The new system called “ARIEL” stands for Advanced Research and Innovation Ethics and Logistics. With the same look and feel as the one used by Clinical Trials Ontario (CTO), ARIEL is cloud-based to streamline all phases of the REB application process – from submission to review, renewal, and closure. It will make processes smoother for researchers who are seeking REB approval and volunteer REB members who ensure that each study meets the highest ethical standards.

Only online submissions through ARIEL will be accepted (no paper form) moving forward.

New information related to COVID-19 – At North York General Hospital, your health and safety are our priority as a research participant. We are promoting social distancing to prevent and slow the spread of the novel coronavirus, COVID-19. We are carefully considering what this means for your research participation and have developed an FAQ to help answer your questions (PDF). Please contact your research coordinator and/or study doctor with any additional questions. As the situation could change over time, please also consult the NYGH website COVID-19 page for up-to-date information.

The North York General Hospital Research Ethics Board (REB) works with investigators to ensure that all research involving human participants or human materials conducted within and on behalf of North York General meets the current scientific and ethical standards of safety, confidentiality and quality to protect research participants.

The REB adheres to diverse national and international key ethical documents and guidelines such as the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2); the International Conference on Harmonization (ICH): Good Clinical Practices (GCP); and the Personal Health Information and Protection Act (PHIPA) Ontario.

The Federal wide Assurance (FWA) number of NYGH REB is FWA00009323